G01N33/57449 - page 2 - CPC Classification Index

#301

20160354427

2016-12-08

METHODS FOR INDUCING EPITHELIAL CANCER CELL SENESCENCE

#302

20160340743

2016-11-24

RECURRENT FUSION GENES IDENTIFIED IN HIGH -GRADE SEROUS OVARIAN CARCINOMA

#303

20160334398

2016-11-17

Nano-plasmonic sensor for exosome detection

#304

20160320396

2016-11-03

Methods for detecting and treating cancer

#305

20160311921

2016-10-27

METHODS FOR TREATMENT OF OVARIAN CANCER

#306

20160299147

2016-10-13

SCREENING, DIAGNOSIS, PROGNOSTICATION AND TREATMENT OF OVARIAN CANCER

#307

20160291026

2016-10-06

BIOMARKERS FOR DETECTION OF OVARIAN CANCER

#308

20160291025

2016-10-06

AUTOANTIBODY BIOMARKERS OF OVARIAN CANCER

#309

20160291024

2016-10-06

Biomarkers for Ovarian Cancer

#310

20160274119

2016-09-22

METHODS AND PRODUCTS FOR THE DIAGNOSIS AND PROGNOSIS OF OVARIAN TUMOR MALIGNANCY

#311

20160266128

2016-09-15

Composition comprising lysophosphatidylcholine and homocysteic acid for ovarian cancer diagnosis and method using the same

#312

20160258960

2016-09-08

DETECTION OF CANCER BY ELEVATED LEVELS OF BCL-2

#313

20160253454

2016-09-01

METHOD OF EVALUATING FEMALE GENITAL CANCER

#314

20160251397

2016-09-01

Akt-specific capture agents, compositions, and methods of using and making

#315

20160245818

2016-08-25

Predictive biomarkers for ovarian cancer

#316

20160231312

2016-08-11

Markers for the epithelial and proliferative or mesenchymal invasive phenotype of human neoplasia

#317

20160224745

2016-08-04

MOLECULAR PROFILING OF TUMORS

#318

20160216267

2016-07-28

Detection of ovarian cancer using antibody arrays

#319

20160175437

2016-06-23

PROTEIN

#320

20160139130

2016-05-19

DETECTING CANCER WITH ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES

#321

20160109455

2016-04-21

COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICTY

#322

20160097102

2016-04-07

Serine proteases as biomarkers for ovarian cancer

#323

20160069886

2016-03-10

BIOMARKERS FOR EARLY DETECTION OF OVARIAN CANCER

#324

20160061840

2016-03-03

Ovarian cancer-specific aptamers and applications thereof

#325

20160054325

2016-02-25

MOLECULAR PROFILING OF TUMORS

#326

20160053006

2016-02-25

Compositions and methods relating to inhibiting cancer cell growth and/or proliferation

#327

20160047815

2016-02-18

METHOD OF DIAGNOSING OR PROGNOSING EPITHELIAL OVARIAN CANCER

#328

20160047000

2016-02-18

METHODS AND SYSTEMS FOR TREATMENT OF OVARIAN CANCER

#329

20160033512

2016-02-04

DIAGNOSIS OF CARCINOMAS

#330

20160018402

2016-01-21

Identification of cancer protein biomarkers using proteomic techniques

#331

20160009816

2016-01-14

Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy

#332

20160002344

2016-01-07

Anti-RSPO2 antibodies and uses thereof

#333

20150377882

2015-12-31

METHOD OF THERAPY

#334

20150366869

2015-12-24

Compostions and methods for treating chemosensory dysfunction

#335

20150355185

2015-12-10

USING GALECTIN-BINDING CARBOHYDRATES AS PREDICTORS OF MELANOMA PROGRESSION AND METASTASIS

#336

20150353629

2015-12-10

Compositions and methods of use for determination of HE4a

#337

20150337384

2015-11-26

IN VITRO METHOD FOR THE DIAGNOSIS AND SURVEILLANCE OF CANCER

#338

20150330985

2015-11-19

GALECTIN-7 AS A BIOMARKER FOR DIAGNOSIS, PROGNOSIS AND MONITORING OF OVARIAN AND RECTAL CANCER

#339

20150322530

2015-11-12

Molecular signatures of ovarian cancer

#340

20150293104

2015-10-15

EPITHELIAL OVARIAN CANCER DIFFERENTIATION MARKER

#341

20150292027

2015-10-15

Papanicolaou test for ovarian and endometrial cancers

#342

20150284809

2015-10-08

Molecular biomarker set for early detection of ovarian cancer

#343

20150276747

2015-10-01

BIOMARKERS FOR OVARIAN CANCER

#344

20150252430

2015-09-10

Methods for the identification, assessment, and treatment of patients with cancer therapy

#345

20150250864

2015-09-10

ANTI-CANCER VACCINES

#346

20150232563

2015-08-20

Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II

#347

20150209378

2015-07-30

Effective treatment of ovarian cancer using triciribine and related compounds

#348

20150191798

2015-07-09

HOXC6 AND OVARIAN CANCER METHODS AND USES THEREOF

#349

20150182644

2015-07-02

Compounds and methods for the detection of TRPV-6 cancers and drug delivery

#350

20150168414

2015-06-18

Methods and Compositions for Personalized Medicine by Point-of-Care Devices for FSH, LH, HCG and BNP

#351

20150160227

2015-06-11

Methods of detecting and treating stem-cell containing solid tumors

#352

20150153348

2015-06-04

BIOMARKERS FOR OVARIAN CANCER: Beta 2 MICROGLOBULIN

#353

20150147823

2015-05-28

Methods and compositions for personalized medicine by point-of-care devices for brain natriuretic peptide

#354

20150147330

2015-05-28

High-affinity monoclonal antibodies to glypican-3 and use thereof

#355

20150139980

2015-05-21

Detectors of serum biomarkers for predicting ovarian cancer recurrence

#356

20150132218

2015-05-14

Anti-Ly6E antibodies and methods of use

#357

20150111227

2015-04-23

Peptide specific for ovarian cancer and applications

#358

20150110897

2015-04-23

Sperm Protein as a Detection Biomarker of Early Stage Ovarian Cancer

#359

20150094377

2015-04-02

Hereditary cancer genes

#360

20150094362

2015-04-02

Anti-CXCR1 compositions and methods

#361

20150093388

2015-04-02

Monoclonal antibodies for detection of folate receptor 1

#362

20150080269

2015-03-19

Molecular profiling of tumors

#363

20150080249

2015-03-19

O-glycan pathway ovarian cancer signature

#364

20150065388

2015-03-05

Anti-mesothelin antibodies and immunoconjugates

#365

20150065368

2015-03-05

Method for the in vitro diagnosis or prognosis of ovarian cancer

#366

20150044703

2015-02-12

METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER

#367

20150031624

2015-01-29

Anti-mesothelin chimeric antigen receptors

#368

20150031561

2015-01-29

BIOMARKER PANELS, DIAGNOSTIC METHODS AND TEST KITS FOR OVARIAN CANCER

#369

20150030543

2015-01-29

Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis

#370

20150025810

2015-01-22

ASSAY TO DETECT A GYNECOLOGICAL CONDITION

#371

20150024952

2015-01-22

MOLECULAR PROFILING FOR CANCER

#372

20150011594

2015-01-08

BIN1 expression as a marker of cancer

#373

20150010926

2015-01-08

METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY HCG ASSAY

#374

20150010571

2015-01-08

Anti-RSPO2 antibodies

#375

20150010565

2015-01-08

Anti-RSPO1 antibodies and uses thereof

#376

20150005187

2015-01-01

Biomarkers of Cancer

#377

20150004633

2015-01-01

ASSAYS AND METHODS FOR THE DIAGNOSIS OF OVARIAN CANCER

#378

20140364341

2014-12-11

PREDICTIVE MARKERS AND BIOMARKERS FOR OVARIAN CANCER

#379

20140363446

2014-12-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#380

20140342924

2014-11-20

Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent

#381

20140341897

2014-11-20

Anti-folate receptor alpha antibodies and uses thereof

#382

20140315743

2014-10-23

Methods and Compositions for the Treatment and Diagnosis of Ovarian Cancer

#383

20140314750

2014-10-23

Six-Gene Biomarker of Survival and Response to Platinum Based Chemotherapy in Serious Ovarian Cancer Patients

#384

20140296098

2014-10-02

Diagnostic and Prognostic Markers for Cancer

#385

20140295455

2014-10-02

Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer

#386

20140294730

2014-10-02

Compositions and methods for diagnosing and monitoring ovarian cancer progression and treatment

#387

20140274927

2014-09-18

TNF-Related Biomarkers For Assessing Cancer Cell Response To Treatment With Taxane And/Or Anthracycline Drugs

#388

20140274794

2014-09-18

Methods and Compositions for Diagnosis of Ovarian Cancer

#389

20140274787

2014-09-18

Biomarker for ovarian cancer CTAP3-related proteins

#390

20140255411

2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#391

20140255389

2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#392

20140242612

2014-08-28

SYSTEM AND METHOD FOR INTEGRATION OF MOBILE DEVICE IMAGING WITH MICROCHIP ELISA

#393

20140242607

2014-08-28

Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer

#394

20140228423

2014-08-14

BIOMARKERS AND THERAPY FOR CANCER

#395

20140221240

2014-08-07

Predictive markers for ovarian cancer

#396

20140220011

2014-08-07

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#397

20140212897

2014-07-31

Methods for predicting pregnancy outcome in a subject by hCG assay

#398

20140199242

2014-07-17

Compositions and methods for detection and treatment of cancer

#399

20140194366

2014-07-10

Ovarian cancer stem cells and methods of isolation and uses thereof

#400

20140193919

2014-07-10

Methods of detecting ovarian cancer

#401

20140186264

2014-07-03

Extracellular vesicle-associated protein markers of cancer

#402

20140179808

2014-06-26

Detection of Ovarian Carcinoma by Assay for Autoantibodies to Multiple Antigens

#403

20140162891

2014-06-12

METHODS AND MATERIALS FOR DETECTION, DIAGNOSIS AND MANAGEMENT OF OVARIAN CANCER

#404

20140148353

2014-05-29

PROTEIN EXPRESSION-BASED CLASSIFIER FOR PREDICTION OF RECURRENCE IN ADENOCARCINOMA

#405

20140142057

2014-05-22

Effective treatment of ovarian cancer using triciribine and related compounds

#406

20140141992

2014-05-22

Neoepitope detection of disease using protein arrays

#407

20140100130

2014-04-10

Methods and compositions for the diagnosis of ovarian cancer

#408

20140099324

2014-04-10

HERV-K antigens, antibodies, and methods

#409

20140073654

2014-03-13

Methods for diagnosing and treating loss or distortion of taste

#410

20140038837

2014-02-06

BIOMARKERS FOR THE DETECTION OF EARLY STAGE OVARIAN CANCER

#411

20140024552

2014-01-23

COMPOSITIONS AND METHODS FOR DIAGNOSING OVARIAN CANCER

#412

20140017703

2014-01-16

Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival

#413

20140005059

2014-01-02

BIOMARKERS FOR CANCER

#414

20130344168

2013-12-26

Compositions and methods APC, CREB, and BAD pathways to assess and affect cancer

#415

20130280246

2013-10-24

Humanized antibodies with anti-tumor activity

#416

20130217047

2013-08-22

Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof

#417

20130183299

2013-07-18

Anti-folate receptor alpha antibodies and uses thereof

#418

20130164215

2013-06-27

Compositions and methods for detecting, diagnosing, and treating cancer

#419

20130157292

2013-06-20

COMPOSITION FOR THE DIAGNOSIS OF OVARIAN CANCER OR PNEUMONIA COMPRISING THIOREDOXIN 1 AS ACTIVE INGREDIENT AND USE THEREOF

#420

20130130939

2013-05-23

PORTABLE PHOTONIC SENSOR SYSTEM AS AN EARLY DETECTION TOOL FOR OVARIAN CANCER

#421

20130090256

2013-04-11

Biomarkers for early detection of ovarian cancer

#422

20130060549

2013-03-07

METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS

#423

20130058966

2013-03-07

ANTI-PDEF ANTIBODIES AND USES THEREOF

#424

20130045947

2013-02-21

PLA2ACTIVITY AS A MARKER FOR OVARIAN AND OTHER GYNECOLOGIC CANCERS

#425

20130045479

2013-02-21

Methods for evaluating the stage of ovarian cancer or the survival rate of an ovarian cancer patient

#426

20130039909

2013-02-14

Predicting response to a HER inhibitor

#427

20130023426

2013-01-24

Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids

#428

20130022998

2013-01-24

Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer

#429

20130017195

2013-01-17

Anti-folate receptor alpha antibodies and uses thereof

#430

20130013334

2013-01-10

Methods for the identification, assessment, and treatment of patients with cancer therapy

#431

20130012409

2013-01-10

Diagnostic and Prognostic Markers for Cancer

#432

20130011858

2013-01-10

Methods for predicting pregnancy outcome in a subject by hCG assay

#433

20130011853

2013-01-10

Anti-hedgehog antibodies

#434

20130004955

2013-01-03

Ovary tumor markers and methods of use thereof

#435

20120329079

2012-12-27

Pro108 Antibody Compositions and Methods of Use and Use of Pro108 to Assess Cancer Risk

#436

20120315662

2012-12-13

METHOD FOR THE EARLY DETECTION OF HIGH-GRADE PELVIC SEROUS CANCER

#437

20120309640

2012-12-06

Diagnostic and Prognostic Markers for Cancer

#438

20120295814

2012-11-22

CA-125 Immune Complexes as Biomarkers of Ovarian Cancer

#439

20120295275

2012-11-22

Monoclonal antibodies and uses thereof

#440

20120288498

2012-11-15

POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER

#441

20120283115

2012-11-08

SEROMIC ANALYSIS OF OVARIAN CANCER

#442

20120277326

2012-11-01

BIOMARKERS OF CANCER

#443

20120264140

2012-10-18

Methods and kits to detect and monitor ovarian cancer and preeclampsia

#444

20120263647

2012-10-18

Pro104 Antibody Compositions and Methods of Use

#445

20120252036

2012-10-04

Diagnostic tests for abnormal ovarian conditions

#446

20120238478

2012-09-20

PROTEIN MARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF OVARIAN AND BREAST CANCER

#447

20120231090

2012-09-13

Molecular biomarker set for early detection of ovarian cancer

#448

20120225013

2012-09-06

Anti-mesothelin antibodies and immunoconjugates

#449

20120220540

2012-08-30

SYNBODIES TO AKT1

#450

20120220476

2012-08-30

Biomarkers for ovarian cancer

#451

20120214828

2012-08-23

DETERMINING SENSITIVITY OF CELLS TO B-RAF INHIBITOR TREATMENT BY DETECTING KRAS MUTATION AND RTK EXPRESSION LEVELS

#452

20120207771

2012-08-16

FOLATE RECEPTOR ALPHA AS A DIAGNOSTIC AND PROGNOSTIC MARKER FOR FOLATE RECEPTOR ALPHA-EXPRESSING CANCERS

#453

20120202226

2012-08-09

METHOD AND SYSTEM FOR THE DETECTION OF CANCER

#454

20120201751

2012-08-09

Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44

#455

20120178757

2012-07-12

Method For The Prevention Of Cancer Metastasis

#456

20120171694

2012-07-05

PREDICTIVE MARKERS AND BIOMARKER PANELS FOR OVARIAN CANCER

#457

20120165253

2012-06-28

Methods for inhibiting peritoneal dissemination of cancer cells

#458

20120165217

2012-06-28

Cancer Biomarkers and Uses Thereof

#459

20120157335

2012-06-21

Flap Endonuclease-1 As A Marker For Cancer

#460

20120156225

2012-06-21

Method of therapy

#461

20120134997

2012-05-31

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#462

20120128587

2012-05-24

FOLATE-TARGETED DIAGNOSTICS AND TREATMENT

#463

20120114948

2012-05-10

Granules with reduced dust potential comprising an antifoam agent

#464

20120093819

2012-04-19

Antibodies that specifically block the biological activity of kidney associated antigen 1 (KAAG1)

#465

20120082993

2012-04-05

DETECTING CANCER WITH ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES

#466

20120076724

2012-03-29

Serpentine transmembrane antigens expressed in human cancers and uses thereof

#467

20120058204

2012-03-08

USE OF OVER EXPRESSION OF CYSTATHIONINE GAMMA LYASE AS A PROGNOSTIC, DIAGNOSTIC AND THERAPEUTIC TARGET FOR CANCER

#468

20120053225

2012-03-01

AKT tyrosine 176 phosphorylation cancer biomarker

#469

20120052071

2012-03-01

TUMOR MARKERS AND METHODS OF USE THEREOF

#470

20120046185

2012-02-23

PANEL OF BIOMARKERS FOR OVARIAN CANCER

#471

20120046182

2012-02-23

Neoepitope detection of disease using protein arrays

#472

20120045439

2012-02-23

Tumor markers and methods of use thereof

#473

20120028829

2012-02-02

ANTI-HEDGEHOG ANTIBODIES

#474

20120014872

2012-01-19

Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers

#475

20120014870

2012-01-19

Diagnosis and Treatment of Cancer Using Anti-LGR7 Antibody

#476

20120004854

2012-01-05

METABOLIC BIOMARKERS FOR OVARIAN CANCER AND METHODS OF USE THEREOF

#477

20120004289

2012-01-05

ANNEXIN A11 AND ASSOCIATED GENES AS BIOMARKERS FOR CANCER

#478

20110318763

2011-12-29

DETECTION OF CANCER BY ELEVATED LEVELS OF BCL-2

#479

20110318344

2011-12-29

Tumor Treatment

#480

20110306049

2011-12-15

METHOD FOR DETECTING GYNECOLOGIC CANCER

#481

20110300557

2011-12-08

Methods for predicting pregnancy outcome in a subject by hCG assay

#482

20110287949

2011-11-24

Methods for detecting and treating cancer

#483

20110281277

2011-11-17

COMPOSITION, KIT, AND METHOD FOR DIAGNOSING COLORECTAL CANCER OR OVARIAN CANCER

#484

20110269171

2011-11-03

METHODS AND MATERIALS FOR USING NKAP POLYPEPTIDE EXPRESSION LEVELS OR PATTERNS TO DETECT OR ASSESS CANCER

#485

20110262929

2011-10-27

Anti-HS6ST2 antibodies and uses thereof

#486

20110256560

2011-10-20

METHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN CANCER

#487

20110256554

2011-10-20

Methods for predicting pregnancy outcome in a subject by hCG assay

#488

20110246399

2011-10-06

PREDICTING RESPONSE TO A HER INHIBITOR

#489

20110245103

2011-10-06

PREDICTING RESPONSE TO A HER INHIBITOR

#490

20110229481

2011-09-22

Cancer-associated antigen analogue peptides and uses thereof

#491

20110223107

2011-09-15

Anti-kidney associated antigen 1 (KAAG1) antibodies

#492

20110217701

2011-09-08

Prognostic Marker for Endometrial Carcinoma

#493

20110217309

2011-09-08

BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE INHIBITORS

#494

20110217238

2011-09-08

Method of Diagnosing or Prognosing Epithelial Ovarian Cancer

#495

20110213337

2011-09-01

Methods for the early diagnosis of ovarian cancer

#496

20110190149

2011-08-04

Neoepitope detection of disease using protein arrays

#497

20110178154

2011-07-21

GENE EXPRESSION PROFILE THAT PREDICTS OVARIAN CANCER SUBJECT RESPONSE TO CHEMOTHERAPY

#498

20110177525

2011-07-21

ANTIBODIES AND METHODS OF DIAGNOSING DISEASES

#499

20110167505

2011-07-07

GFATS As Modifiers of the AXIN Pathway and Methods of Use

#500

20110166095

2011-07-07

Cancer platinum resistance detection and sensitization method

#501

20110159526

2011-06-30

Methods for predicting pregnancy outcome in a subject by hCG assay

#502

20110159518

2011-06-30

Method for the diagnosis of the presence of an ovarian cancer

#503

20110150882

2011-06-23

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER

#504

20110143444

2011-06-16

METHOD OF EVALUATING FEMALE GENITAL CANCER

#505

20110137016

2011-06-09

Compositions and methods for the diagnosis and treatment of tumor

#506

20110129483

2011-06-02

Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy

#507

20110104675

2011-05-05

Methods and Compositions for Diagnosing Carcinomas

#508

20110086056

2011-04-14

Methods for the early diagnosis of ovarian cancer

#509

20110081650

2011-04-07

FREE NGAL AS A BIOMARKER FOR CANCER

#510

20110077931

2011-03-31

METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS

#511

20110059543

2011-03-10

Methods for detecting or monitoring cancer using LPE as a marker

#512

20110045508

2011-02-24

Urinary CA125 peptides as biomarkers of ovarian cancer

#513

20110045502

2011-02-24

Monoclonal antibodies and uses thereof

#514

20110039282

2011-02-17

METHOD OF DETECTING CALCIFYING NANOPARTICLES AND SUSCEPTIBILITY TO CALCIFYING NANOPARTICLE INFORMATION

#515

20110038883

2011-02-17

HE4 MONOCLONAL ANTIBODIES AND METHODS FOR THEIR USE

#516

20110033867

2011-02-10

Use of biomarkers for detecting ovarian cancer

#517

20110033852

2011-02-10

PRESENT INVENTION RELATES TO METHODS FOR PREDICTION OF THE THERAPEUTIC SUCCESS OF BREAST CANCER THERAPY

#518

20110033839

2011-02-10

Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids

#519

20110033377

2011-02-10

ASSAY TO DETECT A GYNECOLOGICAL CONDITION

#520

20110028343

2011-02-03

Biomarkers of ovarian cancer

#521

20110027283

2011-02-03

Methods for diagnosing and treating cancers

#522

20110021451

2011-01-27

Lipid tumour profile

#523

20110015259

2011-01-20

TLE3 as a marker for chemotherapy

#524

20100331249

2010-12-30

Pharmaceutical composition for inhibiting peritoneal dissemination

#525

20100330593

2010-12-30

METHODS AND COMPOSITIONS FOR DIAGNOSING NEOPLASTIC DISEASE

#526

20100329983

2010-12-30

COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY

#527

20100325743

2010-12-23

Marks as modifiers of the p53 pathway and methods of use

#528

20100317013

2010-12-16

Methods and compositions for detecting spermatozoa or semen in a sample

#529

20100311047

2010-12-09

Identification of cancer protein biomarkers using proteomic techniques

#530

20100304993

2010-12-02

BIOMARKERS FOR THE DETECTION OF EARLY STAGE OVARIAN CANCER

#531

20100304989

2010-12-02

Molecular profiling of tumors

#532

20100297134

2010-11-25

Humanised antibodies with anti-tumour activity

#533

20100292451

2010-11-18

METHOD FOR DIAGNOSING SELECTED ADENOCARCINOMAS

#534

20100292087

2010-11-18

Method of predicting chemotherapeutic responsiveness of cancer

#535

20100291690

2010-11-18

METHODS FOR DETECTING OR MONITORING CANCER USING LPC AS A MARKER

#536

20100291689

2010-11-18

Lanthanide Complexes as Fluorescent Indicators for Neutral Sugars and Cancer Diagnosis

#537

20100291068

2010-11-18

NUCLEIC ACID MOLECULES AND PROTEINS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF OVARIAN CANCER

#538

20100284915

2010-11-11

GENES ASSOCIATED WITH CHEMOTHERAPY RESPONSE AND USES THEREOF

#539

20100284910

2010-11-11

Method of diagnosing, monitoring, staging, imaging and treating various cancers

#540

20100275275

2010-10-28

HADHs as Modifiers of the p21 Pathway and Methods of Use

#541

20100273160

2010-10-28

Collecting ovarian cancer stem cells from ovarian cancer cells

#542

20100272635

2010-10-28

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND/OR PROGNOSIS IN OVARIAN CANCER AND LUNG CANCER

#543

20100227875

2010-09-09

Methods for detection of biological substances

#544

20100227343

2010-09-09

Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer

#545

20100227335

2010-09-09

MATRIX METALLOPROTEINASE-7 (MMP-7) MONOCLONAL ANTIBODIES AND METHODS FOR THEIR USE IN THE DETECTION OF OVARIAN CANCER

#546

20100221752

2010-09-02

Ovarian Cancer Biomarkers and Uses Thereof

#547

20100209959

2010-08-19

TUMOUR-CELL-FIXING CELLS

#548

20100203012

2010-08-12

IAP BIR DOMAIN BINDING COMPOUNDS

#549

20100197561

2010-08-05

Biomarkers for Ovarian Cancer: B2 Microglobulin

#550

20100196924

2010-08-05

Method for diagnosing tumors

#551

20100190662

2010-07-29

METHODS AND MATERIALS FOR DETECTION, DIAGNOSIS AND MANAGEMENT OF OVARIAN CANCER

#552

20100190200

2010-07-29

Diagnosis of Gynecological Neoplasms By Detecting The Levels of Oviduct-Specific Glycoprotein

#553

20100190199

2010-07-29

GPR30 ESTROGEN RECEPTOR IN BREAST AND OVARIAN CANCERS

#554

20100166652

2010-07-01

Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody

#555

20100160348

2010-06-24

MATERIALS AND METHODS FOR DETECTING AND TREATING PERITONEAL OVARIAN TUMOR DISSEMINATION INVOLVING TISSUE TRANSGLUTAMINASE

#556

20100159470

2010-06-24

SCDs as modifiers of the p53 pathway and methods of use

#557

20100158916

2010-06-24

Diagnostic biomolecule(s)

#558

20100150901

2010-06-17

26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor

#559

20100144838

2010-06-10

Methods for Identifying Modulators of Pyrimidine Tract Binding Protein

#560

20100136583

2010-06-03

Method for Diagnosing Tumors by Measuring the Level of Apolipoprotein A-IV

#561

20100136031

2010-06-03

Breast tumor treatment with anti-CXCR1 compositions

#562

20100136017

2010-06-03

Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer

#563

20100124786

2010-05-20

Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer

#564

20100111956

2010-05-06

Antigen polypeptide for the diagnosis and/or treatment of ovarian cancer

#565

20100105067

2010-04-29

Biomarkers for ovarian cancer

#566

20100099095

2010-04-22

Methods for determining prognoses and therapeutic interventions for ovarian carcinomas

#567

20100098628

2010-04-22

PROTEINS

#568

20100098627

2010-04-22

PROTEINS

#569

20100098626

2010-04-22

Protein

#570

20100086960

2010-04-08

METHODS FOR THE DIAGNOSIS OF OVARIAN CANCER HEALTH STATES AND RISK OF OVARIAN CANCER HEALTH STATES

#571

20100086948

2010-04-08

Ovarian Cancer Biomarkers and Uses Thereof

#572

20100086537

2010-04-08

Polynucleotides and polypeptide sequences involved in cancer

#573

20100081151

2010-04-01

Biomarkers for early detection of ovarian cancer

#574

20100075354

2010-03-25

Marker for identification of tissue type of epithelial ovarian cancer, and method for determination of the occurrence of epithelial ovarian cancer based on tissue type by using the marker

#575

20100075344

2010-03-25

Methods, assays and kits for cancer diagnosis and screening utilizing glycan-binding and glycan epitopes

#576

20100075342

2010-03-25

Biomarker for ovarian cancer CTAP3-related proteins

#577

20100074893

2010-03-25

ECM-Complex Antibody Compositions and Methods of Use

#578

20100068818

2010-03-18

ALGORITHMS FOR MULTIVARIANT MODELS TO COMBINE A PANEL OF BIOMARKERS FOR ASSESSING THE RISK OF DEVELOPING OVARIAN CANCER

#579

20100068724

2010-03-18

Biomaker for ovarian and endometrial cancer: hepcidin

#580

20100062444

2010-03-11

TLE3 as a marker for chemotherapy

#581

20100055690

2010-03-04

PROGNOSTIC BIOMARKERS IN PATIENTS WITH OVARIAN CANCER

#582

20100047847

2010-02-25

Methods for diagnosing ovarian cancer

#583

20100047818

2010-02-25

Diagnosis of carcinomas

#584

20100015639

2010-01-21

Methods and kits to detect and monitor ovarian cancer and preeclampsia

#585

20100015625

2010-01-21

CTIP2 expression in squamous cell carcinoma

#586

20100008975

2010-01-14

Predicting response to a HER inhibitor

#587

20100003705

2010-01-07

Cln101 Antibody Compositions and Methods of Use Alone and in Combination with Prostate Specific Antigen and Other Cancer Markers

#588

20100003239

2010-01-07

Anti-hedgehog antibodies

#589

20090325200

2009-12-31

POLYPYRIMIDINE-TRACT BINDING PROTEIN (PTB) AS A BIOMARKER AND TARGET FOR THE DIAGNOSIS AND TREATMENT OF CANCER

#590

20090305266

2009-12-10

TEST FOR OVARIAN CANCER BY DETECTING ABNORMALITY IN FANCD2 PATHWAY

#591

20090304578

2009-12-10

Cancerous Disease Modifying Antibodies

#592

20090298053

2009-12-03

Use of novel biomarkers for detection of testicular carcinoma in situ and derived cancers in human samples

#593

20090297530

2009-12-03

HERV-K ANTIGENS, ANTIBODIES, AND METHODS

#594

20090285861

2009-11-19

Tumor cell-based cancer immunotherapeutic compositions and methods

#595

20090280493

2009-11-12

Methods and Compositions for the Prediction of Response to Trastuzumab Containing Chemotherapy Regimen in Malignant Neoplasia

#596

20090263411

2009-10-22

Compositions, splice variants and methods relating to ovarian specific genes and proteins

#597

20090258378

2009-10-15

Stress-induced phosphoprotein 1 as a biomarker for the detection of human ovarian cancers and endometriosis

#598

20090252735

2009-10-08

Peptides for development of diagnostic and therapeutic agents and methods of using same

#599

20090246769

2009-10-01

MOLECULAR DIAGNOSIS OF OVARIAN CANCERS

#600

20090239818

2009-09-24

EFFECTIVE TREATMENT OF OVARIAN CANCER USING TRICIRIBINE AND RELATED COMPOUNDS